| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | Class A ordinary share, par value $0.0001 per share | 27.7% | $142M | 19.8M | BVF PARTNERS L P/IL | Nov 6, 2025 | ||
| IVA | Inventiva S.A. | Ordinary Shares, nominal value (euro)0.01 per share | 6.1% | $26.9M | 8.55M | 0% | BVF PARTNERS L P/IL | May 7, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|